Iradimed

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$21,202
$20,409
$19,510
$19,389
Gross Profit
16,494
15,954
14,842
14,760
EBITDA
7,681
7,919
5,625
6,539
EBIT
7,297
7,327
5,431
6,344
Net Income
5,576
5,773
4,687
5,146
Net Change In Cash
21,202
20,409
19,510
19,389
Free Cash Flow
5,848
4,922
594
2,930
Cash
56,526
52,995
50,330
52,233
Basic Shares
12,860
12,830
12,825
12,783

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$73,242
$65,562
$53,303
$41,814
Gross Profit
56,349
50,158
41,282
32,049
EBITDA
22,782
20,035
16,298
11,224
EBIT
21,964
20,035
15,627
9,817
Net Income
19,234
17,192
12,827
9,325
Net Change In Cash
73,242
65,562
53,303
41,814
Cost of Revenue
-4,038
11,930
Free Cash Flow
17,619
5,457
8,167
10,516
Cash
52,233
49,762
57,960
61,999
Basic Shares
12,783
12,722
12,635
12,590

Earnings Calls

QuarterEPS
2025-09-30
$0.47
2025-06-30
$0.49
2025-03-31
$0.37
2024-12-31
$0.40